[go: up one dir, main page]

GB2146351B - Monoclonal antibody - Google Patents

Monoclonal antibody

Info

Publication number
GB2146351B
GB2146351B GB08423719A GB8423719A GB2146351B GB 2146351 B GB2146351 B GB 2146351B GB 08423719 A GB08423719 A GB 08423719A GB 8423719 A GB8423719 A GB 8423719A GB 2146351 B GB2146351 B GB 2146351B
Authority
GB
United Kingdom
Prior art keywords
monoclonal antibody
monoclonal
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08423719A
Other versions
GB8423719D0 (en
GB2146351A (en
Inventor
David Stanley Secher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB8423719D0 publication Critical patent/GB8423719D0/en
Publication of GB2146351A publication Critical patent/GB2146351A/en
Application granted granted Critical
Publication of GB2146351B publication Critical patent/GB2146351B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB08423719A 1983-02-04 1984-02-06 Monoclonal antibody Expired GB2146351B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838303165A GB8303165D0 (en) 1983-02-04 1983-02-04 Monoclonal antibody
PCT/GB1984/000031 WO1984003105A1 (en) 1983-02-04 1984-02-06 Monoclonal antibody

Publications (3)

Publication Number Publication Date
GB8423719D0 GB8423719D0 (en) 1984-10-24
GB2146351A GB2146351A (en) 1985-04-17
GB2146351B true GB2146351B (en) 1986-10-22

Family

ID=10537497

Family Applications (2)

Application Number Title Priority Date Filing Date
GB838303165A Pending GB8303165D0 (en) 1983-02-04 1983-02-04 Monoclonal antibody
GB08423719A Expired GB2146351B (en) 1983-02-04 1984-02-06 Monoclonal antibody

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB838303165A Pending GB8303165D0 (en) 1983-02-04 1983-02-04 Monoclonal antibody

Country Status (4)

Country Link
EP (1) EP0134803A1 (en)
JP (1) JPS60500714A (en)
GB (2) GB8303165D0 (en)
WO (1) WO1984003105A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306060A1 (en) * 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim NEW IMMUNGLOBULIN-PRODUCING HYBRID CELL LINES, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
FR2560212B1 (en) * 1984-02-24 1989-12-29 Unicet MONOCLONAL ANTIBODIES AGAINST INTERFERON A2 AND HYBRIDOMAS PRODUCING SUCH ANTIBODIES
DK0741577T3 (en) * 1994-03-07 2003-02-17 Imperial College The use of enterferon, subtype alpha 8, in the manufacture of drugs for the treatment of viral infections in the liver
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
BRPI0720035A2 (en) 2006-12-06 2019-05-07 Medimmune, Llc methods for treating a patient having a disease or disorder, for treating a patient with autoimmune disease, for neutralizing an ifn inducible type 1 or ifnalfa pd marker expression profile in a patient, for monitoring or predicting autoimmune disease progression of a patient to monitor disease progression of a patient receiving treatment with a therapeutic agent that binds to and modulates ifnalfa activity, to identify a patient as a candidate for a therapeutic agent that binds to and modulates the activity of ifnalfa ifnalfa, to diagnose a patient as having a disorder associated with increased ifnalfa levels, to identify a therapeutic candidate for the treatment of ifnalfa-mediated disorders, and to detect ifn activity in a sample, probe set, and kit
JP2010526107A (en) 2007-05-03 2010-07-29 メディミューン，エルエルシー Autoantibody markers for autoimmune diseases
SI2219452T1 (en) 2007-11-05 2016-03-31 Medimmune, Llc Methods of treating scleroderma
ES2529593T3 (en) 2008-02-08 2015-02-23 Medimmune, Llc Disease markers and their uses
MX2012002640A (en) 2009-09-03 2012-06-25 Medimmune Llc Type 1 interferon diagnostic.
CA3128785A1 (en) 2019-02-15 2020-08-20 Astrazeneca Ab Type i interferon-mediated disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2083836B (en) * 1980-04-11 1984-03-28 Burke Derek Clissold Monoclonal antibody
US4514507A (en) * 1980-11-07 1985-04-30 Secher David S Assay for interferon
FR2500754B1 (en) * 1981-02-27 1986-06-27 Hoffmann La Roche MONOCLONAL ANTIBODIES

Also Published As

Publication number Publication date
GB8303165D0 (en) 1983-03-09
GB8423719D0 (en) 1984-10-24
WO1984003105A1 (en) 1984-08-16
GB2146351A (en) 1985-04-17
EP0134803A1 (en) 1985-03-27
JPS60500714A (en) 1985-05-16

Similar Documents

Publication Publication Date Title
GB8316001D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
GB8431152D0 (en) Lymphokine monoclonal antibody
GB8426463D0 (en) Monoclonal antibodies
GB8422653D0 (en) Monoclonal antibodies
GB8426467D0 (en) Monoclonal antibodies
GB2146351B (en) Monoclonal antibody
GB2163178B (en) Novel monoclonal antibody
ZA85681B (en) Monoclonal antibody
GB8330331D0 (en) Monoclonal antibody
GB8504271D0 (en) Monoclonal antibody
GB8426461D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
GB8422651D0 (en) Monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies
GB8426470D0 (en) Monoclonal antibodies
GB8431171D0 (en) Monoclonal antibodies
GB8419456D0 (en) Monoclonal antibodies
GB8426465D0 (en) Monoclonal antibodies
GB8416845D0 (en) Monoclonal antibodies
GB8426469D0 (en) Monoclonal antibodies
GB8326508D0 (en) Monoclonal anti-superoxide dismutase antibody
GB8306617D0 (en) Specific antibody

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee